EG

PARKER DOYLE NAMED CHIEF OPERATING OFFICER & PARTNER AT THE MOSELEY GROUP

Retrieved on: 
Friday, April 19, 2024
TMG, Parker, Senior, Food, Farm, Multimedia, Drink, Growth, Management

FRANKLIN, Mass., April 19, 2024 /PRNewswire/ -- The Moseley Group CEO Harry Milloff announced today the promotion of Parker Doyle to COO, overseeing the global foodservice consultancy's team performance and client integration.

Key Points: 
  • FRANKLIN, Mass., April 19, 2024 /PRNewswire/ -- The Moseley Group CEO Harry Milloff announced today the promotion of Parker Doyle to COO, overseeing the global foodservice consultancy's team performance and client integration.
  • "Parker has a passion for transforming the way the world perceives and interacts with food and beverages," said Milloff.
  • Milloff also announced that Tom Moseley III has been added to The Moseley Group team, bringing his background in brand strategy, restaurant operations, and digital marketing to the group.
  • The Moseley Group, defines, executes, and delivers innovative solutions that optimize client metrics, improve guest experiences, and drive new growth.

OceanaGold Extends High-Grade Mineralization at Wharekirauponga and Welcomes New Zealand's New Fast Track Approvals Bill

Retrieved on: 
Thursday, March 7, 2024
Mining, TSX, Growth, Learning, Government, WKP, Regional development, Mineral Resources Limited, OceanaGold, Uranium mining

The Company also welcomes yesterday's announcement by New Zealand's recently elected Government to create a new one-stop-shop fast track consenting (permitting) regime that will promote streamlined processes for regional and national projects of significance.

Key Points: 
  • The Company also welcomes yesterday's announcement by New Zealand's recently elected Government to create a new one-stop-shop fast track consenting (permitting) regime that will promote streamlined processes for regional and national projects of significance.
  • For more information on the Fast Track Approvals Bill, please see the Government of New Zealand's announcement at https://www.beehive.govt.nz/release/one-stop-shop-major-projects-fast-track .
  • Gerard Bond, President & CEO of OceanaGold, said "Today's drill results align with our strategy of adding value through near-mine resource conversion and growth.
  • The recently announced introduction of the Fast Track Approvals Bill signals a new focus by the New Zealand government to facilitate the delivery of significant development projects, including mining.

EG Bio Announces CE Mark Approval for EDEL X™ HA Dermal Filler in the European Market

Retrieved on: 
Monday, February 26, 2024
ISO, CE, Injection, Multimedia, Lidocaine, GMP, Skin, LTD, CE marking, Patient, Face, Cosmetics

SEOUL, South Korea, Feb. 26, 2024 /PRNewswire-PRWeb/ -- EG Bio Co., LTD, a trailblazer in the aesthetic industry, is thrilled to announce that it has obtained CE Mark certification for its innovative product, the EDEL X™ HA Dermal Filler, making it available for the European market. This milestone underscores EG Bio Co., LTD's commitment to providing safe, high-quality aesthetic solutions on a global scale.

Key Points: 
  • SEOUL, South Korea, Feb. 26, 2024 /PRNewswire-PRWeb/ -- EG Bio Co., LTD , a trailblazer in the aesthetic industry, is thrilled to announce that it has obtained CE Mark certification for its innovative product, the EDEL X™ HA Dermal Filler, making it available for the European market.
  • This milestone underscores EG Bio Co., LTD's commitment to providing safe, high-quality aesthetic solutions on a global scale.
  • EDEL X™ is a state-of-the-art hyaluronic acid (HA) dermal filler enhanced with lidocaine, designed for safe and comfortable injections.
  • The introduction of EDEL X™ HA Dermal Filler with Lidocaine marks a new epoch in cosmetic enhancements and helps reduce the appearance of lines and wrinkles.

flyExclusive Announces $25 Million Strategic Investment from ETG FE, LLC

Retrieved on: 
Friday, January 26, 2024
Professional Services, Air, Transport, Transportation, Finance, Travel, Other Transport, Partnership, Global TransPark, ETG, Safety, Growth

flyExclusive (NYSEAMERICAN: FLYX) (“flyExclusive” or the “Company”), a publicly-traded provider of premium private jet charter experiences, today announced the execution of a two-year revolving credit facility for up to $25.8 million with ETG FE LLC, an investment vehicle managed by EnTrust Global.

Key Points: 
  • flyExclusive (NYSEAMERICAN: FLYX) (“flyExclusive” or the “Company”), a publicly-traded provider of premium private jet charter experiences, today announced the execution of a two-year revolving credit facility for up to $25.8 million with ETG FE LLC, an investment vehicle managed by EnTrust Global.
  • As part of its strategic initiatives to accelerate operational excellence, grow the business, and execute its strategic plan to become the nation’s first fully vertically integrated private aviation company, flyExclusive will use the proceeds to support the continued evolution of the company’s fractional aircraft program.
  • “We believe this facility is a strong vote of confidence in flyExclusive’s strategy and continued initiatives to increase growth and profitability,” said Jim Segrave, Founder and CEO of flyExclusive.
  • In October 2023, the Company announced that the Global TransPark secured a $30 million investment from the State of North Carolina to fund a new headquarters and cutting-edge pilot training center.

EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB)

Retrieved on: 
Thursday, January 4, 2024
Overactive bladder, Biotechnology, IND, Sphincter, Drug discovery, OAB, DNA, MD, Human, Animal, Effectiveness, Gene expression, NDO, Urinary tract infection, Patient, Neurology, Vaccine

In the first non-clinical pharmacology study comparing bladder injections of EG110A to botulinum toxin A in OAB, EG110A showed comparable efficacy, and further showed no increase in post-void residual urine volume.

Key Points: 
  • In the first non-clinical pharmacology study comparing bladder injections of EG110A to botulinum toxin A in OAB, EG110A showed comparable efficacy, and further showed no increase in post-void residual urine volume.
  • In the second study, which evaluated EG110A transgene expression over time in the dorsal root ganglia of treated animals, EG110A demonstrated persistent gene expression out to the final six-month time point.
  • These results strongly support the potential for EG110A to provide long-term relief for patients suffering from NDO and OAB.
  • EG 427 will be filing an Investigational New Drug (IND) application for EG110A in the first quarter of this year.

flyExclusive and EG Acquisition Corporation Announce Closing of Business Combination

Retrieved on: 
Wednesday, December 27, 2023
Transport, Air, Special-purpose acquisition company, Economics, LLP, Vinson & Elkins, Acceleration, Management

flyExclusive, a leading provider of premium private jet charter experiences, and EG Acquisition Corp. (NYSE: EGGF), a Special Purpose Acquisition Company (SPAC) sponsored by EnTrust Global and GMF Capital, today announced the completion of their previously announced business combination.

Key Points: 
  • flyExclusive, a leading provider of premium private jet charter experiences, and EG Acquisition Corp. (NYSE: EGGF), a Special Purpose Acquisition Company (SPAC) sponsored by EnTrust Global and GMF Capital, today announced the completion of their previously announced business combination.
  • The business combination was approved at a special meeting of EG Acquisition Corp.’s stockholders on December 18, 2023.
  • “Today marks another milestone in our company’s mission to elevate the private aviation experience,” said Jim Segrave, Chief Executive Officer and founder of flyExclusive.
  • In connection with the closing of the business combination, the Company has canceled the annual meeting, which was previously scheduled to be held on December 27, 2023 at 5:00 p.m. Eastern Time.

EG Acquisition Corp. Announces Update on Business Combination and Annual Meeting

Retrieved on: 
Thursday, December 21, 2023
Professional Services, Finance, Special-purpose acquisition company, Business analyst, Person, Date, Special, Trust, Annual general meeting, Name, Extension, Annual, Communication, Security (finance)

Following and subject to the consummation of the Business Combination, flyExclusive’s Class A common stock and public warrants would trade on the NYSE American under the symbols “FLYX” and “FLYXW,” respectively.

Key Points: 
  • Following and subject to the consummation of the Business Combination, flyExclusive’s Class A common stock and public warrants would trade on the NYSE American under the symbols “FLYX” and “FLYXW,” respectively.
  • The record date for determining the Company stockholders entitled to receive notice of and to vote at the Annual Meeting remains the close of business on December 4, 2023 (the “Record Date”).
  • Stockholders who do not wish to withdraw their previously submitted redemption requests (either in connection with the Special Meeting or the upcoming Annual Meeting) need not take any further action.
  • This communication does not contain all the information that should be considered concerning the Annual Meeting.

EG Acquisition Corp. Announces Update on Business Combination and Annual Meeting

Retrieved on: 
Tuesday, December 19, 2023
Professional Services, Finance, Transfer, Special-purpose acquisition company, Business analyst, Person, Date, Special, Trust, Annual general meeting, Name, Extension, Annual, Communication

Approximately 97% of the shares that voted on the Business Combination voted in favor of it, representing approximately 90% of the outstanding shares of EG’s common stock.

Key Points: 
  • Approximately 97% of the shares that voted on the Business Combination voted in favor of it, representing approximately 90% of the outstanding shares of EG’s common stock.
  • The record date for determining the Company stockholders entitled to receive notice of and to vote at the Annual Meeting remains the close of business on December 4, 2023 (the “Record Date”).
  • Stockholders who do not wish to withdraw their previously submitted redemption requests (either in connection with the Special Meeting or the upcoming Annual Meeting) need not take any further action.
  • This communication does not contain all the information that should be considered concerning the Annual Meeting.

QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers

Retrieved on: 
Thursday, November 9, 2023
Research, NYSE, DNA, Chemistry, Senior, Prevalence, Food, PCR, Workflow, Nested polymerase chain reaction, Software, QGEN, Temperature, QIAGEN, RNA, Medical device

The QIAcuity OneStep Advanced EG Kit allows researchers the highly sensitive quantification of RNA or RNA alongside DNA in one reaction.

Key Points: 
  • The QIAcuity OneStep Advanced EG Kit allows researchers the highly sensitive quantification of RNA or RNA alongside DNA in one reaction.
  • The kit uses intercalating dye technology that makes procedures easier to design and more cost-efficient than those used in fluorescent-probe-based PCR.
  • QIAcuity mericon Food Testing Kits are the only ready-to-use digital PCR food tests on the market.
  • “The launch of our new QIAcuity kits and the software update emphasize QIAGEN’s dedication to advancing digital PCR analysis in crucial sectors like pharma, biopharma research, and food and drug safety,” said Nitin Sood, Senior Vice President and Head of the Life Sciences Business Area at QIAGEN.

EG Acquisition Corp. Announces Intention to Transfer Listing from The New York Stock Exchange and Planned Listing by flyExclusive on NYSE American LLC Upon Consummation of its Pending Business Combination

Retrieved on: 
Saturday, December 16, 2023
Professional Services, Air, Transport, Finance, LGM, NYSE, Business analyst, Security (finance), Special-purpose acquisition company, NYSE American, Person, Communication, Name

The Company’s Class A common stock and public warrants will continue to trade on the NYSE under the symbols “EGGF” and “EGGFW,” respectively, until and subject to the consummation of the Business Combination.

Key Points: 
  • The Company’s Class A common stock and public warrants will continue to trade on the NYSE under the symbols “EGGF” and “EGGFW,” respectively, until and subject to the consummation of the Business Combination.
  • Following and subject to the consummation of the Business Combination, flyExclusive’s Class A common stock and public warrants would trade on the NYSE American under the symbols “FLYX” and “FLYXW,” respectively.
  • This communication does not contain all the information that should be considered concerning the Business Combination.
  • It is not intended to provide the basis for any investment decision or any other decision in respect to the proposed Business Combination.